Phase II Randomized Study of BAX2398 in Combination With 5-Fluorouracil and Calcium Levofolinate in Japanese Patients With Metastatic Pancreatic Cancer, Which Progressed or Recurred After Prior Gemcitabine-Based Therapy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2018
At a glance
- Drugs Irinotecan (Primary) ; Fluorouracil; Levofolinic acid
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Baxalta; Shire
- 20 Apr 2018 Planned End Date changed from 13 Apr 2018 to 15 May 2018.
- 20 Apr 2018 Planned primary completion date changed from 13 Apr 2018 to 15 May 2018.
- 18 Jan 2018 Planned End Date changed from 1 Dec 2017 to 13 Apr 2018.